Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy
Lukáš Górecki, Martin Andrš, Martina Řezáčová, Jan Korábečný
Topics & Concepts
RadioresistanceMedicineCancerDrug discoveryRadiation therapyBiomarkerClinical trialCancer researchTargeted therapyPharmacologyOncologyBioinformaticsComputational biologyInternal medicineBiologyBiochemistryDNA Repair MechanismsPARP inhibition in cancer therapyCancer-related Molecular Pathways